Researchers sought to determine risk of venous thromboembolism, based on SAVED and IMPEDE VTE scores, in patients with newly diagnosed multiple myeloma.

Recurrent venous thromboembolism developed in 38 of the 360 patients (10.6 percent). Patients with recurrence had higher mean (±SD) plasma levels of factor VIII than those without recurrence (182 ...

Nurses. Pharmacists. ... It is still generally accepted that efficacious venous thromboembolism prophylaxis during this period will ... in 1995, it was 6.6 days, half of the patients going ...

Venous thromboembolism, though rare in the community, is a major cause of death among hospitalized patients. It is estimated to cause 100,000 deaths per year and to contribute to mortality in ...